Javascript must be enabled to continue!
Vitamin C for Sepsis and Septic Shock
View through CrossRef
Background:
Sepsis remains a leading cause of death in the critically ill. The combination of thiamine, vitamin C, and hydrocortisone has recently emerged as a potential adjunctive therapy and supportive care for patients with sepsis and septic shock.
Areas of Uncertainty:
Several randomized and observational controlled trials evaluated the role of vitamin C in sepsis and septic shock. However, there are variabilities in the findings of these studies that led to a substantial global debate on incorporating vitamin C therapy in clinical practice.
Data Sources:
A PubMed and Embase English language literature search through April 2021 was performed using the following terms: ascorbic acid, vitamin C, corticosteroid, hydrocortisone, thiamine, HAT, sepsis, and shock. Citations, including controlled trials, observational studies, review articles, guidelines, and consensus statements, were reviewed. The risk of bias for each clinical study was systematically evaluated. Relevant clinical data focusing on efficacy, safety, and special considerations regarding the use of vitamin C with and without thiamine and hydrocortisone in sepsis and septic shock were narratively summarized.
Results:
The most commonly used vitamin C dosing in sepsis and septic shock is 1.5 g every 6 hours with and without thiamine and hydrocortisone. Current literature is limited because of heterogeneity in vitamin C regimen used, initiation time, and duration of treatment. This limitation led to variability in outcomes evaluated. Vitamin C decreases proinflammatory mediators and slows the progression of endothelial injury in severe sepsis. There is an inconsistency between randomized controlled trials and observational controlled trials regarding mortality, resolution in organ failure, hospital and intensive care unit length of stay findings with the use of vitamin C in septic shock. Vitamin C seems to be safe in comparison with placebo.
Conclusions:
Future studies with consistent end points, initiation time with an emphasis on early initiation, and standard vitamin C dosing regimen are needed to determine the overall benefit of vitamin C in sepsis.
Ovid Technologies (Wolters Kluwer Health)
Title: Vitamin C for Sepsis and Septic Shock
Description:
Background:
Sepsis remains a leading cause of death in the critically ill.
The combination of thiamine, vitamin C, and hydrocortisone has recently emerged as a potential adjunctive therapy and supportive care for patients with sepsis and septic shock.
Areas of Uncertainty:
Several randomized and observational controlled trials evaluated the role of vitamin C in sepsis and septic shock.
However, there are variabilities in the findings of these studies that led to a substantial global debate on incorporating vitamin C therapy in clinical practice.
Data Sources:
A PubMed and Embase English language literature search through April 2021 was performed using the following terms: ascorbic acid, vitamin C, corticosteroid, hydrocortisone, thiamine, HAT, sepsis, and shock.
Citations, including controlled trials, observational studies, review articles, guidelines, and consensus statements, were reviewed.
The risk of bias for each clinical study was systematically evaluated.
Relevant clinical data focusing on efficacy, safety, and special considerations regarding the use of vitamin C with and without thiamine and hydrocortisone in sepsis and septic shock were narratively summarized.
Results:
The most commonly used vitamin C dosing in sepsis and septic shock is 1.
5 g every 6 hours with and without thiamine and hydrocortisone.
Current literature is limited because of heterogeneity in vitamin C regimen used, initiation time, and duration of treatment.
This limitation led to variability in outcomes evaluated.
Vitamin C decreases proinflammatory mediators and slows the progression of endothelial injury in severe sepsis.
There is an inconsistency between randomized controlled trials and observational controlled trials regarding mortality, resolution in organ failure, hospital and intensive care unit length of stay findings with the use of vitamin C in septic shock.
Vitamin C seems to be safe in comparison with placebo.
Conclusions:
Future studies with consistent end points, initiation time with an emphasis on early initiation, and standard vitamin C dosing regimen are needed to determine the overall benefit of vitamin C in sepsis.
Related Results
VITAMIN D INSUFFICIENCY IN FOUR MAJOR HOSPITALS OF PUNJAB
VITAMIN D INSUFFICIENCY IN FOUR MAJOR HOSPITALS OF PUNJAB
Objective: To demonstrate vitamin D deficiency in the general population of Punjab
Study Design: Observational, Cross-Sectional
Place and Duration: Multicentre study co...
Importance of vitamin D in critically ill children with subgroup analyses of sepsis and respiratory tract infections: a systematic review and meta-analysis
Importance of vitamin D in critically ill children with subgroup analyses of sepsis and respiratory tract infections: a systematic review and meta-analysis
Summary
Background
Critical care and sepsis remain high priority concerns in children. Observational studies report high preval...
Neurological Complications in Sepsis
Neurological Complications in Sepsis
Background: Sepsis is a medical emergency that requires immediate assessment and management. Sepsis can affect patients at any age group which increases the number of sepsis cases....
Impacts of the COVID-19 pandemic on sepsis incidence, etiology and hospitalization costs in France: a retrospective observational study
Impacts of the COVID-19 pandemic on sepsis incidence, etiology and hospitalization costs in France: a retrospective observational study
Abstract
Background
Sepsis is a serious medical condition that causes long-term morbidity and high mortality, annually affectin...
Clinical Profiles, Interventions, and Outcomes of Sepsis and Septic Shock in a Saudi Arabian Tertiary ICU: A Five-Year Retrospective Analysis
Clinical Profiles, Interventions, and Outcomes of Sepsis and Septic Shock in a Saudi Arabian Tertiary ICU: A Five-Year Retrospective Analysis
Background and Objectives: Sepsis and septic shock remain leading causes of morbidity and mortality in intensive care settings worldwide. While substantial epidemiological data exi...
Early Recognition and Treatment of Sepsis and Its Impact on Mortality and ICU Outcomes: A Retrospective Cohort Study from Gaza, Palestine
Early Recognition and Treatment of Sepsis and Its Impact on Mortality and ICU Outcomes: A Retrospective Cohort Study from Gaza, Palestine
Sepsis remains a leading cause of intensive care unit (ICU) admission and in-hospital mortality worldwide, with a disproportionately high burden in low-resource and conflict-affect...
Differential gene expression analysis reveals novel genes and pathways in pediatric septic shock patients
Differential gene expression analysis reveals novel genes and pathways in pediatric septic shock patients
Abstract
Septic shock is a severe health condition caused by uncontrolled sepsis. Advancements in the high-throughput sequencing techniques have risen the number of...
To Determine The Association Of Serum Neopterin Levels In Sepsis
To Determine The Association Of Serum Neopterin Levels In Sepsis
Abstract
ABSTRACT
Background: Sepsis is a leading cause of death worldwide. Sepsis results in state of multiorgan dysfunction in the body. Early identification and appropri...

